Xianju Pharmaceutical Co., Ltd. announced its plan to repurchase shares worth between RMB 80 million and RMB 150 million for employee incentive programs. The repurchase price is capped at RMB 13.25 per share, following adjustments after the 2025 annual equity distribution. As of May 31, 2026, the company has not yet initiated the share repurchase process.
Summary generated by AI · Always verify with source document
Zhejiang Xianju Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.